The early weeks on a prescription weight-loss medication set the tone for everything that follows. Doses are typically titrated, appetite cues change, and side effects can appear as routines shift. What you track during this window can help your clinician make better decisions and help you protect lean mass, manage symptoms, and avoid common mistakes. This practical guide outlines a week-by-week focus for the first 12 weeks, with specific metrics, tools, and scenarios that make the data you collect useful rather than overwhelming.
Establish a Baseline Before Your First Dose
Before starting a GLP-1 receptor agonist like semaglutide, or another agent such as phentermine, orlistat, or bupropion-naltrexone, capture baseline measurements that you can repeat at set intervals. Record morning weight, waist circumference at the navel, and resting heart rate. Take front and side progress photos in the same lighting. If you monitor blood pressure at home, log readings at the same time each day. Keep a 3- to 7-day food diary that records meals, beverages, and alcohol, and add step counts from your phone or wearable device. If you are still learning about commonly used medicines, a concise overview of names and classes is available on this website.
Set up simple tools so you do not miss data later: a smart scale synced to an app, a fabric tape measure, a habit tracker for workouts, and a symptom log with space for hunger ratings, nausea, or sleep. If your clinician orders labs, keep copies of your A1C, fasting glucose, lipid panel, and liver enzyme results together. These anchors will help you see whether weight changes reflect fat loss, water shifts, or muscle changes, and whether side effects line up with dose changes or meal patterns.
Weeks 1 to 4: Titration, Appetite Shifts, and GI Symptom Tracking
As doses begin and gradually increase, appetite typically drops on GLP-1s such as semaglutide or tirzepatide. Pair that with a structured symptom diary. Log meal timing, portion sizes, and post-meal comfort. Note nausea, reflux, constipation, or diarrhea using a simple 1-10 scale and, if you know it, the Bristol stool chart description. Small, protein-forward meals, eating more slowly, and staying hydrated often improve tolerability. For orlistat, track fat grams at each meal and any oily stools or urgency. That relationship is direct: higher-fat meals frequently trigger more GI symptoms with orlistat.
Non-GLP-1 medicines have their own monitoring priorities. With phentermine or phentermine-topiramate, track resting heart rate, blood pressure, and sleep quality, as stimulatory effects can increase pulse and disrupt sleep. With bupropion-naltrexone, log cravings, mood changes, and headaches. With metformin, watch for GI upset and note whether taking it with food reduces symptoms. Scenario: a desk-based professional on semaglutide notices morning nausea after large cups of coffee. Splitting breakfast into two small meals and reducing acidic drinks may help while doses are being titrated. Share patterns like these with your clinician before the next adjustment.
Weeks 5 to 8: Protein, Resistance Training, and Preserving Lean Mass
By week 5, appetite suppression can make it easy to under-eat protein and skip strength work, both of which increase the risk of losing muscle along with fat. Make protein visible at each meal with options like eggs, Greek yogurt, cottage cheese, poultry, fish, tofu, or tempeh, and track grams per meal in your food app. Log two or three resistance sessions weekly that cover major movement patterns: squats or leg presses, hinges like deadlifts or hip thrusts, rows and pulls, and presses. Write down sets, reps, and loads so you can apply gradual increases, even if small.
Add objective measures of body composition where possible. A DEXA scan offers precision but is not essential; consistent waist measurements and progress photos reveal fat loss that the scale can hide. Scenario: a parent training at home sees the scale drop 10 pounds but notices declining push-up reps and a shrinking thigh circumference. That pattern suggests muscle loss. Respond by prioritizing one more strength session, adding a protein-rich snack after workouts, and checking sleep duration. These adjustments help align lower appetite with muscle-preserving behaviors.
Weeks 9 to 12: Plateaus, Dose Checks, and Lifestyle Tweaks
Plateaus often emerge as your body adapts to lower calorie intake and lighter body weight. Repeat a 3-day food log to spot untracked items like sauces, alcohol, or frequent bites while cooking. If you dine out more on weekends, highlight it. Increase non-exercise activity by scheduling walking meetings, using a timer for 5-minute movement breaks, or adding 1,000 to 2,000 steps to your daily total above your current average. For sleep, aim for a consistent bedtime and limit late-day caffeine, because short sleep can drive hunger via shifts in leptin and ghrelin levels.
Discuss dose changes with your prescribing clinician rather than escalating quickly on your own. Fast titrations can worsen GI side effects on GLP-1s, reducing adherence and quality of life. Phentermine-related increases in heart rate or blood pressure warrant a pause for evaluation. For orlistat users, reducing total fat intake helps reduce unpleasant stools. If stress is high, experiment with a 10-minute evening walk, brief breathing exercises, or time-blocked meal prep. These small, trackable changes can break a plateau without turning the first months into an unsustainable grind.
Red Flags That Warrant a Clinician’s Input
Certain symptoms should prompt a check-in. Persistent vomiting, signs of dehydration, or severe abdominal pain need timely evaluation, especially right upper quadrant pain after meals on a GLP-1, which can relate to the gallbladder. On phentermine, sustained resting heart rates well above your baseline, chest pain, or new palpitations are not “push through it” signs. Black or tarry stools, fainting, or sudden mood changes with bupropion-naltrexone should be reported promptly. If you use diabetes medications that can cause hypoglycemia, log any shakiness, sweating, or confusion and contact your clinician to discuss adjustments.
Treat these first 12 weeks as a structured trial. Use reproducible metrics, simple tools, and short notes that reveal dose-response relationships rather than relying on memory. Medications can lower appetite or alter absorption, but lasting results come from pairing them with resistance training, adequate protein, hydration, sleep, and stress management you can maintain. Bring your logs to each telehealth or in-person follow-up, and ask specific questions about patterns you see. The clearer the data you collect, the easier it is for your care team to tailor a safe, sustainable plan that fits real life.
